*Report is based on an internet-based survey of 322 chronic pain patients. Participants altered their oral opioid treatment by missing a dose, decreasing, or stopping treatment to ease a BM.4
†Report is based on an annual cross-sectional survey of 2430 patients (mean age 50-52 years) receiving opioids. Health-related quality-of-life was evaluated using the Short-Form 8 Health Survey.5
Learn about the causes of OIC
To report SUSPECTED ADVERSE REACTIONS, contact Salix at 1-800-508-0024 or FDA at 1-800-FDA-1088 or www.fda.gov/Safety/MedWatch/
Please click here for full Prescribing Information for RELISTOR tablets and RELISTOR injection.